The Third Generation Sequencing Market is estimated to be valued at US$ 8.93 Bn in 2022 and is expected to exhibit a CAGR of 13.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Third generation sequencing, also known as single-molecule real-time (SMRT) sequencing, enables scientists to directly observe DNA and RNA polymerases as they synthesize new strands of DNA or RNA. Thisallows DNA sequencing of long strands of nucleic acids without needing to fragment the DNA first. Products associated with this market include sequencers, consumables such as chips and reagents, and analysis platforms for life science research, diagnostics and therapeutics.

Market Dynamics:
The third generation sequencing market is driven by the increasing demand for long read sequencing capabilities to sequence complex genomes and resolve structural variations. Unlike prior generations sequencing technologies, third generation systems can sequence long strands of nucleic acids in the range of 10,000 to 1 million base pairs in length. This allows for phasing of structural variants and haplotypes that prior technologies struggle with. Additionally, advancements in nanopore sequencing technology by key players are enabling portable, real-time and affordable sequencing without the need for laboratory infrastructure. Players like Oxford Nanopore Technologies are commercializing handheld sequencing devices to enable sequencing at the point-of-care. These drivers are expected to support the double digit growth of this Third Generation Sequencing Market over the forecast period.

Read More : https://www.feedsfloor.com/pharmaceuticals/third-generation-sequencing-market-estimated-witness-high-growth-owing-efficient